INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$85K

$85,906

Total Sells (Filtered)

$0

$0

View Raw Line-Items

Live Feed: 2026-03-11

Timeline

Side

Size

All $1M+ $5M+ $10M+

Role

Ticker Search

Clear Clear Filters

Ticker	Company	Reporting Owner	Date	Value (USD)	Type	Form 4
APRE P Aprea Therapeutics, Inc. Gilad Oren • CEO Discretionary Buy 2026-01-30 $25,009 View Form 4 →
APRE	Aprea Therapeutics, Inc.	Gilad Oren CEO Discretionary Buy	2026-01-30	$25,009	P	Form 4
APRE P Aprea Therapeutics, Inc. Hamill John P. • CFO Discretionary BuyΔOwn +20.6% 2026-01-30 $5,073 View Form 4 →
APRE	Aprea Therapeutics, Inc.	Hamill John P. CFO Discretionary BuyΔOwn +20.6%	2026-01-30	$5,073	P	Form 4
APRE P Aprea Therapeutics, Inc. Duey Marc • Director Discretionary Buy 2025-12-10 $25,000x2 View Form 4 →
APRE	Aprea Therapeutics, Inc.	Duey Marc Director Discretionary Buy	2025-12-10	$25,000x2	P	Form 4
APRE P Aprea Therapeutics, Inc. Gilad Oren • CEO Discretionary Buy 2025-12-10 $25,000x2 View Form 4 →
APRE	Aprea Therapeutics, Inc.	Gilad Oren CEO Discretionary Buy	2025-12-10	$25,000x2	P	Form 4
APRE P Aprea Therapeutics, Inc. Hamill John P. • CFO Discretionary BuyΔOwn +22.0% 2025-12-10 $5,825x2 View Form 4 →
APRE	Aprea Therapeutics, Inc.	Hamill John P. CFO Discretionary BuyΔOwn +22.0%	2025-12-10	$5,825x2	P	Form 4